BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19953089)

  • 21. Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort.
    Eglinton TW; Roberts R; Pearson J; Barclay M; Merriman TR; Frizelle FA; Gearry RB
    Am J Gastroenterol; 2012 Apr; 107(4):589-96. PubMed ID: 22158027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease.
    Biank V; Friedrichs F; Babusukumar U; Wang T; Stoll M; Broeckel U; Kugathasan S
    Am J Gastroenterol; 2007 Feb; 102(2):391-8. PubMed ID: 17156146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population.
    Simms LA; Doecke JD; Roberts RL; Fowler EV; Zhao ZZ; McGuckin MA; Huang N; Hayward NK; Webb PM; Whiteman DC; Cavanaugh JA; McCallum R; Florin TH; Barclay ML; Gearry RB; Merriman TR; Montgomery GW; Radford-Smith GL
    Am J Gastroenterol; 2010 Oct; 105(10):2209-17. PubMed ID: 20407432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study.
    Reif S; Lavy A; Keter D; Fich A; Eliakim R; Halak A; Broide E; Niv Y; Ron Y; Patz J; Odes S; Villa Y; Gilat T
    Am J Gastroenterol; 2000 Feb; 95(2):474-8. PubMed ID: 10685753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease.
    Amre DK; Mack DR; Morgan K; Israel D; Lambrette P; Costea I; Krupoves A; Fegury H; Dong J; Grimard G; Deslandres C; Levy E; Seidman EG
    Aliment Pharmacol Ther; 2009 May; 29(9):1025-31. PubMed ID: 19210299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M; Corneliussen B; Costello CM; Waetzig GH; Mellgard B; Koch WA; Rosenstiel P; Albrecht M; Croucher PJ; Seegert D; Nikolaus S; Hampe J; Lengauer T; Pierrou S; Foelsch UR; Mathew CG; Lagerstrom-Fermer M; Schreiber S
    Nat Genet; 2004 May; 36(5):476-80. PubMed ID: 15107852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
    Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
    Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
    Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn's disease.
    Sehgal R; Berg A; Polinski JI; Hegarty JP; Lin Z; McKenna KJ; Stewart DB; Poritz LS; Koltun WA
    Dis Colon Rectum; 2012 Feb; 55(2):115-21. PubMed ID: 22228152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease.
    Doecke JD; Simms LA; Zhao ZZ; Roberts RL; Fowler EV; Croft A; Lin A; Huang N; Whiteman DC; Florin TH; Barclay ML; Merriman TR; Gearry RB; Montgomery GW; Radford-Smith GL
    J Gastroenterol Hepatol; 2015 Feb; 30(2):299-307. PubMed ID: 24989722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children.
    Amre DK; Mack DR; Morgan K; Israel D; Deslandres C; Seidman EG; Lambrette P; Costea I; Krupoves A; Fegury H; Dong J; Grimard G; Levy E
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1186-91. PubMed ID: 20222910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the PTPN2 gene and Crohn's disease: dissection of potential causal variants.
    Marcil V; Mack DR; Kumar V; Faure C; Carlson CS; Beaulieu P; Israel D; Krupoves A; Costea I; Lambrette P; Grimard G; Dong J; Seidman EG; Amre DK; Levy E
    Inflamm Bowel Dis; 2013 May; 19(6):1149-55. PubMed ID: 23518806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.